Galena Biopharma Inc


Company Update (NASDAQ:GALE): Galena Biopharma Inc Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …

Biotech Beat: FBR Analysts Weigh In on Galena Biopharma Inc (GALE), Peregrine Pharmaceuticals (PPHM) and Immune Pharmaceuticals Inc (IMNP)

Galena Biopharma Inc FBR analyst Vernon Bernardino weighs in on Galena Biopharma Inc (NASDAQ:GALE), after the biotech company announced that the FDA has given Fast …

Biotech Beat: Analysts Weigh In On Galena Biopharma Inc (GALE) And Celgene Corporation (CELG)

Galena Biopharma Inc Galena Biopharma Inc (NASDAQ:GALE) shares jumped over 22% today after the cancer therapeutics company announced that NeuVax has gained fast track designation …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Receives Fast Track Designation for NeuVax™ PRESENT Clinical Trial

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …

Biotech Beat: Analysts Weigh in on Endo International plc – Ordinary Shares (ENDP) and Galena Biopharma Inc (GALE)

Analysts recently weighed in on two healthcare stocks Endo International plc – Ordinary Shares (NASDAQ:ENDP) and Galena Biopharma Inc (NASDAQ:GALE). While one analyst …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Reports First Quarter 2016 Financial Results and Provides a Corporate Update

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Appoints Mary Ann Gray, Ph.D., to Its Board of Directors

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, today …

Company Update (NASDAQ:GALE): Galena Biopharma Inc Presents GALE-301/GALE-302 Clinical Booster Data at the AACR Annual Meeting

Galena Biopharma Inc (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs, announced …

ACADIA Pharmaceuticals Inc (ACAD) and Galena Biopharma Inc (GALE) Attract Analysts Following Positive FDA Panel and Phase 3 Results

Stocks in the biotech sector are notoriously volatile pending pending FDA approvals and new drug trials. Analysts weigh in on ACADIA Pharmaceuticals Inc.

Roth Capital Analysts Cut Price Targets for Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI) But Remain Positive

Roth Capital analysts weighed in on Galena Biopharma Inc (NASDAQ:GALE) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) following Q4:15 earnings from both companies.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts